Fridays vs Remedy Meds vs PlexusDx: Which GLP-1 Program Fits?

Last reviewed: September 1, 2026 Last updated: September 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Fridays, Remedy Meds, and PlexusDx occupy distinct positions on the cost-versus-support spectrum. Fridays bundles unlimited provider visits, one-on-one dietitian support, nutrition coaching, mental-health coaching, and care coaching into a single monthly price—$249 for semaglutide or $359 for tirzepatide—with zero membership, signup, or lab fees. That comprehensive bundle commands a premium: you pay $2,988/year for semaglutide or $4,308/year for tirzepatide on the month-to-month plan. Remedy Meds showed only a microdose option in its intake funnel, priced at $189/month ($2,268/year), backed by a "guaranteed or it's free" results warranty and unlimited video visits with a 100% U.S.-based care team; the program publishes no prices on its website and did not present a standard-dose pathway when we captured evidence on July 20, 2026. PlexusDx publishes transparent pricing across five formats: microdose GLP-1 at $129/month month-to-month ($1,548/year), semaglutide injection at $189/month month-to-month ($2,268/year), tirzepatide injection at $289/month month-to-month ($3,468/year), oral semaglutide at $289/month, and oral tirzepatide at $349/month, with lower committed-term rates available and a free pharmacist check-in included. If you value integrated behavioral support and unlimited access to dietitians and coaches, Fridays justifies its higher cost. If you prefer a microdose regimen with a results guarantee and are comfortable with a post-intake pricing model, Remedy Meds offers that pathway. If you want published pricing, format choice, and the lowest month-to-month rates for standard-dose compounds, PlexusDx delivers decision-grade transparency and cost efficiency. Each program's advantages are real; the right choice depends on whether you prioritize bundled coaching, warranty assurance, or upfront price clarity and variety.

At-a-glance comparison

All figures verified July 17–23, 2026. Fridays pricing captured from joinfridays.com/pricing July 20, 2026; Remedy Meds pricing shown in intake funnel July 20, 2026; PlexusDx pricing verified across product pages July 19–20, 2026.

Like-for-like pricing and 12-month cost

Evidence permits three direct comparisons: Fridays versus PlexusDx on semaglutide and tirzepatide month-to-month plans, and Remedy Meds versus PlexusDx on microdose month-to-month. Fridays publishes no standing multi-month rate; Remedy Meds documented no committed-term pricing. We present month-to-month annualized costs first, then PlexusDx's prepaid options where they exist.

Semaglutide: Fridays $249/month vs PlexusDx $189/month injectable

• Fridays month-to-month: $249/mo × 12 = $2,988/year (our calculation).
• PlexusDx month-to-month: $189/mo × 12 = $2,268/year (our calculation).
• PlexusDx 3-month prepaid: $169/mo × 12 = $2,028/year (our calculation; customer pays $507 every quarter).
• PlexusDx 6-month prepaid: $149/mo × 12 = $1,788/year (our calculation; customer pays $894 every six months).

Cost difference: PlexusDx saves $720/year versus Fridays on month-to-month semaglutide; the 6-month prepaid option saves $1,200/year versus Fridays month-to-month. Fridays includes unlimited provider visits, one-on-one dietitian support, nutrition coaching, mental-health coaching, and a care coach in that $249 price. PlexusDx includes a free pharmacist check-in and offers an optional genetics add-on ($99 for program members, $298 standalone). If you will use the coaching and dietitian access every month, Fridays' incremental $720/year may represent good value; if you prefer self-directed adherence and episodic clinical check-ins, PlexusDx's lower base price and optional add-ons deliver better cost efficiency.

Tirzepatide: Fridays $359/month vs PlexusDx $289/month injectable

• Fridays month-to-month: $359/mo × 12 = $4,308/year (our calculation).
• PlexusDx month-to-month: $289/mo × 12 = $3,468/year (our calculation).
• PlexusDx 3-month prepaid: $269/mo × 12 = $3,228/year (our calculation; customer pays $807 every quarter).
• PlexusDx 6-month prepaid: $249/mo × 12 = $2,988/year (our calculation; customer pays $1,494 every six months).

Cost difference: PlexusDx saves $840/year versus Fridays on month-to-month tirzepatide; the 6-month prepaid option saves $1,320/year. The same support-bundle trade-off applies: Fridays justifies its premium with unlimited coaching and dietitian access; PlexusDx offers a leaner base price and à la carte enhancements. The absolute dollar gap is wider on tirzepatide than semaglutide because the base prices are higher.

Microdose: Remedy Meds $189/month vs PlexusDx $129/month

• Remedy Meds month-to-month: $189/mo × 12 = $2,268/year (our calculation).
• PlexusDx month-to-month: $129/mo × 12 = $1,548/year (our calculation).

Cost difference: PlexusDx saves $720/year on the microdose plan. Remedy Meds backs its $189 price with a "guaranteed or it's free" results warranty (terms apply; we captured the pledge but not the conditions on July 20, 2026), unlimited video visits with clinicians, and always-on phone support from a 100% U.S.-based care team. PlexusDx includes a free pharmacist check-in and offers the optional genetics add-on. Remedy's warranty and unlimited video access justify its premium over PlexusDx if you value that downside protection and frequent touchpoints; if you are comfortable managing a microdose regimen with episodic clinical support, PlexusDx delivers the lower ongoing cost.

Evidence note: Remedy Meds standard-dose availability

Remedy Meds published no standard-dose price on its website and showed only the $189/month microdose option in its intake funnel when we captured evidence on July 20, 2026. We cannot confirm whether Remedy offers standard-dose semaglutide or tirzepatide, or at what price. If you require a standard-dose regimen, confirm availability and cost during your intake before committing.

Evidence note: Fridays price stability

Fridays' campaign landing page displayed pricing that differed from the joinfridays.com/pricing page when we captured both on July 20, 2026. The $249 semaglutide and $359 tirzepatide figures above come from the public pricing page. We recommend confirming your final monthly rate at checkout, especially if you arrive via a marketing campaign.

Decision factors beyond price

Support bundle and coaching intensity

Fridays delivers the most comprehensive behavioral-support package in this comparison: unlimited provider visits, one-on-one dietitian sessions, nutrition coaching, mental-health coaching, and a dedicated care coach, all included in the monthly subscription. The program also requires a comprehensive metabolic panel, hemoglobin A1C, TSH, and lipid panel—standard clinical monitoring for GLP-1 therapy—but charges zero lab fees. If you anticipate needing frequent guidance on meal planning, emotional eating, or motivation, Fridays' all-you-can-use model removes utilization anxiety and may accelerate adherence. Remedy Meds offers unlimited video visits with clinicians and always-on phone support from a 100% U.S.-based care team, emphasizing access and continuity. PlexusDx includes a free pharmacist check-in to review medication logistics, side effects, and adherence strategies, plus an optional genetics test ($99 for program members, $298 standalone) to inform drug-metabolism insights. If you value high-frequency human contact, Fridays or Remedy wins; if you prefer episodic expert touchpoints and self-directed execution, PlexusDx's lean model suffices.

Results warranty and downside protection

Remedy Meds advertises a "guaranteed or it's free" results warranty under its Remedy Weight Loss Warranty; terms apply, and we captured the pledge but not the specific conditions during our July 20, 2026 evidence pass. A results guarantee can reduce financial risk for first-time GLP-1 users, especially on a microdose protocol where efficacy variance may be higher than standard-dose regimens. Neither Fridays nor PlexusDx documented a comparable warranty. If downside protection is a priority, ask Remedy for the warranty's eligibility criteria, measurement window, and refund mechanism during intake.

Format variety and route flexibility

PlexusDx offers five formats: semaglutide injection ($189/month month-to-month), tirzepatide injection ($289/month month-to-month), oral semaglutide ($289/month), oral tirzepatide ($349/month), and microdose GLP-1 ($129/month month-to-month). That variety lets you switch routes—injectable to oral or vice versa—or titrate between microdose and standard-dose without changing providers. Fridays captured two programs (semaglutide and tirzepatide; route not specified in detail in our evidence). Remedy Meds showed only microdose in its intake funnel and published no standard-dose option. If you value the ability to pivot formats as tolerance, efficacy, or lifestyle needs evolve, PlexusDx's product breadth is the clear advantage.

Price transparency and intake friction

PlexusDx publishes all prices on product pages; you know your cost before starting intake. Fridays publishes month-to-month rates on joinfridays.com/pricing, though campaign-page pricing differed when we captured evidence. Remedy Meds publishes no prices on its website; you see cost only after completing the intake quiz. If you screen multiple providers in parallel and want to eliminate options outside your budget before investing time in intake, PlexusDx and Fridays offer that upfront clarity; Remedy requires the intake first. The trade-off: Remedy's post-intake model may allow for more personalized pricing or plan recommendations, though we have no evidence of that variability.

Choose Fridays if…

You want the richest behavioral-support bundle and are willing to pay a premium for it. Fridays' $249 semaglutide or $359 tirzepatide month-to-month plans include unlimited provider visits, one-on-one dietitian support, nutrition coaching, mental-health coaching, and a care coach—resources that can meaningfully accelerate adherence if you engage them consistently. The program charges zero membership, signup, and lab fees, and shipping is free. If you anticipate needing frequent human guidance on meal planning, emotional regulation, or motivation, and you value the convenience of all-inclusive support without per-visit charges, Fridays justifies its $720–$840/year premium over PlexusDx and its $60/month premium over Remedy's microdose plan. The program is best suited to patients who thrive on high-frequency coaching and who will use the bundled resources every month. If you prefer self-directed adherence and episodic clinical check-ins, you will pay for services you underutilize.

Choose Remedy Meds if…

You prefer a microdose GLP-1 regimen, value a results warranty, and are comfortable with a post-intake pricing model. Remedy's $189/month microdose plan includes unlimited video visits with clinicians, always-on phone support from a 100% U.S.-based care team, and a "guaranteed or it's free" results warranty (terms apply). The program ships every 28 days on a month-to-month basis with no long-term commitment. If downside protection matters to you—especially if you are trying GLP-1 therapy for the first time or titrating a microdose protocol where efficacy variance may be higher—Remedy's warranty reduces financial risk. The program's lack of public pricing means you must complete intake to see your cost; if you value that transparency upfront, this creates friction. Remedy's format availability is unclear: we captured only microdose in the intake funnel and saw no published standard-dose option. If you require standard-dose semaglutide or tirzepatide, confirm availability during intake.

Where PlexusDx fits

PlexusDx offers the lowest published month-to-month rates for standard-dose compounds—$189/month month-to-month semaglutide injection, $289/month month-to-month tirzepatide injection—and the most format variety (five total, including oral options and a $129/month month-to-month microdose plan). The program includes a free pharmacist check-in to review medication logistics, side effects, and adherence strategies, plus an optional genetics test ($99 for program members, $298 standalone) that informs drug-metabolism insights. PlexusDx publishes all prices on product pages and offers lower committed-term rates: semaglutide drops to $169/month on the 3-month plan or $149/month on the 6-month plan; tirzepatide drops to $269/month or $249/month. That transparency and cost efficiency appeal to patients who prefer self-directed adherence, episodic expert touchpoints, and the flexibility to switch formats (injectable to oral, standard-dose to microdose, or vice versa) without changing providers. PlexusDx saves $720/year versus Fridays on semaglutide, $840/year on tirzepatide, and $720/year versus Remedy on microdose, all on month-to-month plans. The program does not bundle unlimited coaching or dietitian access, and it offers no results warranty; if you need high-frequency behavioral support or downside protection, Fridays or Remedy better match those priorities. If you value published pricing, format choice, and the lowest month-to-month rates, PlexusDx delivers decision-grade transparency and cost efficiency.

Methodology and freshness

We captured Fridays pricing from joinfridays.com/pricing on July 20, 2026, documenting month-to-month rates for semaglutide ($249) and tirzepatide ($359), zero membership, signup, and lab fees, and the bundled support inclusions (unlimited visits, dietitian, coaching). We noted that Fridays' campaign landing page displayed different pricing on the same date and recommend confirming final rates at checkout. We captured Remedy Meds pricing by completing its intake quiz on July 20, 2026, which presented a $189/month microdose plan with unlimited video visits, always-on phone support, and a results warranty; the program published no prices on its public website and showed no standard-dose option in the funnel. We verified PlexusDx pricing across product pages on July 19–20, 2026, confirming month-to-month and committed-term rates for all five formats and the free pharmacist check-in inclusion. All 12-month cost figures are our calculations: monthly rate × 12. Prepaid per-month equivalents (PlexusDx 3-month and 6-month plans) are our calculations and represent the effective monthly rate when a customer prepays the specified term. We applied standard ongoing rates and prepaid totals only, verified at the dates shown. Where evidence conflicts (Fridays campaign-page versus pricing-page rates, Remedy format availability), we state the conflict plainly and advise confirming at checkout or during intake. No special-offer, limited-time, or early-access figures appear in any calculation.

Frequently Asked Questions

Does Remedy Meds offer standard-dose semaglutide or tirzepatide?

Remedy Meds published no standard-dose price on its website and showed only a $189/month microdose option in its intake funnel when we captured evidence on July 20, 2026. We cannot confirm whether the program offers standard-dose regimens or at what price. If you require standard-dose therapy, ask during your intake and confirm availability and cost before committing.

Why does Fridays cost more than PlexusDx on the same compounds?

Fridays bundles unlimited provider visits, one-on-one dietitian support, nutrition coaching, mental-health coaching, and a care coach into its $249 semaglutide and $359 tirzepatide month-to-month plans. PlexusDx includes a free pharmacist check-in and offers optional add-ons but does not bundle unlimited coaching. If you will use Fridays' support resources consistently, the $720–$840/year premium may deliver value; if you prefer episodic touchpoints, PlexusDx's lean base price is more cost-efficient.

What does Remedy Meds' results warranty cover?

Remedy Meds advertises a "guaranteed or it's free" results warranty under its Remedy Weight Loss Warranty; terms apply. We captured the pledge on July 20, 2026, but not the specific eligibility criteria, measurement window, or refund mechanism. Ask Remedy for the warranty's terms during your intake to understand what downside protection it provides and what conditions you must meet to qualify.

Can I switch from injectable to oral GLP-1 mid-program?

PlexusDx offers both injectable and oral formats for semaglutide and tirzepatide, allowing you to switch routes within the same provider relationship. Fridays and Remedy Meds did not document oral options in our captured evidence; confirm format flexibility during intake if you anticipate wanting to change routes as tolerance or lifestyle needs evolve.

How much do PlexusDx's committed-term plans save versus Fridays?

PlexusDx's 6-month prepaid semaglutide plan costs $1,788/year (our calculation: $149/mo × 12), saving $1,200/year versus Fridays' $2,988/year month-to-month semaglutide plan. PlexusDx's 6-month prepaid tirzepatide plan costs $2,988/year ($249/mo × 12), saving $1,320/year versus Fridays' $4,308/year month-to-month tirzepatide plan. Those savings require prepaying six months ($894 semaglutide, $1,494 tirzepatide) upfront.

Sources

• Fridays pricing page (joinfridays.com/pricing), accessed July 20, 2026
• Fridays campaign landing page, accessed July 20, 2026
• Remedy Meds intake funnel, completed July 20, 2026
• PlexusDx product pages (semaglutide-injection, tirzepatide-injection, semaglutide-oral, tirzepatide-oral, microdose-glp1-protocol), accessed July 19–20, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.